Literature DB >> 2025980

Serum concentration monitoring of cardiac glycosides. How helpful is it for adjusting dosage regimens?

R J Dobbs1, C J O'Neill, A A Deshmukh, P W Nicholson, S M Dobbs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2025980     DOI： 10.2165/00003088-199120030-00001

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  104 in total

1.  Steady-state kinetics of digoxin in the elderly.

Authors:  M A Roberts; F I Caird
Journal:  Age Ageing       Date:  1976-11       Impact factor: 10.668

2.  The dissolution rate of digoxin tablets on the U.K. market: the scale of the problem.

Authors:  D A Cowan; A H Beckett
Journal:  Postgrad Med J       Date:  1974-11       Impact factor: 2.401

3.  A prospective survey of the incidence of cardiac intoxication with digitalis in patients being admitted to hospital and correlation with serum digoxin levels.

Authors:  D Howard; C I Smith; G Stewart; M Vadas; D J Tiller; W J Hensley; J G Richards
Journal:  Aust N Z J Med       Date:  1973-06

4.  Effects of maintenance digoxin therapy on systolic time intervals and serum digoxin concentrations.

Authors:  N H Carliner; C A Gilbert; A W Pruitt; L I Goldberg
Journal:  Circulation       Date:  1974-07       Impact factor: 29.690

5.  Therapeutic non-equivalence of digoxin tablets in the United Kingdom: correlation with tablet dissolution rate.

Authors:  T R Shaw; K Raymond; M R Howard; J Hamer
Journal:  Br Med J       Date:  1973-12-29

6.  The absorption of orally administered (12 - 3 H)digoxin in man.

Authors:  B Beermann; K Hellström; A Rosén
Journal:  Clin Sci       Date:  1972-10       Impact factor: 6.124

7.  Physical exercise and binding of digoxin to skeletal muscle--effect of muscle activation frequency.

Authors:  T Joreteg; T Jogestrand
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 8.  The role of the nervous system in the cardiovascular effects of digitalis.

Authors:  R A Gillis; J A Quest
Journal:  Pharmacol Rev       Date:  1979-03       Impact factor: 25.468

9.  Evaluation of medigoxin in outpatients.

Authors:  W R Smith; E M Rodgers; P W Nicholson; R P Humm; D A Gettins; S M Dobbs; A A Deshmukh
Journal:  Eur J Clin Pharmacol       Date:  1981-03       Impact factor: 2.953

10.  A score for prescribing digoxin.

Authors:  P W Nicholson; S M Dobbs; A P McGill; E M Rodgers; E Slater
Journal:  Br Heart J       Date:  1978-02
View more
  6 in total

1.  The effect of steady-state ropinirole on plasma concentrations of digoxin in patients with Parkinson's disease.

Authors:  A Taylor; A Beerahee; D Citerone; M Davy; K Fitzpatrick; A Lopez-Gil; F Stocchi
Journal:  Br J Clin Pharmacol       Date:  1999-02       Impact factor: 4.335

Review 2.  Therapeutic drug monitoring and patient outcome. A review of the issues.

Authors:  A L Tonkin; F Bochner
Journal:  Clin Pharmacokinet       Date:  1994-09       Impact factor: 6.447

Review 3.  Clinical pharmacokinetics in the 21st century. Does the evidence support definitive outcomes?

Authors:  M H Ensom; G A Davis; C D Cropp; R J Ensom
Journal:  Clin Pharmacokinet       Date:  1998-04       Impact factor: 6.447

Review 4.  Clinical pharmacokinetics of ropinirole.

Authors:  C M Kaye; B Nicholls
Journal:  Clin Pharmacokinet       Date:  2000-10       Impact factor: 6.447

5.  Population pharmacokinetics of digoxin in Japanese patients: a 2-compartment pharmacokinetic model.

Authors:  E Yukawa; F Suematu; M Yukawa; M Minemoto; S Ohdo; S Higuchi; Y Goto; T Aoyama
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

6.  Effect of captopril on functional, physiological and biochemical outcome criteria in aged heart failure patients.

Authors:  C J O'Neill; A Charlett; R J Dobbs; A A Deshmukh; S G Bowes; C Weller; P W Nicholson; J S Milledge; S M Dobbs
Journal:  Br J Clin Pharmacol       Date:  1992-02       Impact factor: 4.335
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.